On 20 January 2014, the company Yakult Pharmaceutical Industry Co., Ltd. informed the Commission, pursuant to Article 5 of Regulation (EC) No 258/97 of the European Parliament and of the Council [Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel foods ingredients (OJ L 43, 14.2.1997, p. 1).], of its intention to place on the market ‘galacto-oligosaccharide’ as a novel food to be used in a number of foods, including infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 of the European Parliament and of the Council [Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (OJ L 181, 29.6.2013, p. 35).]. Therefore, galacto-oligosaccharide was included in the Union list of novel foods.
Recital 3, Regulation (EU) 2021/900
In forcesince 3 Jun 2021
Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 201…Law
- celex=31997R0258
- celex=31992L0052
- celex=31999L0021
- celex=32006L0141
- celex=32009L0039
- celex=32009R0041
- celex=32009R0953
- num:eu=1941/2009
- num:eu=1992/52
- num:eu=1999/21